Stock Events

Stock Events

Bausch Health Companies 

$6.56
170
-$0.20-2.96% Friday 20:00
-$0.06-0.88%Friday 23:30After hours

Statistics

Day High
6.56
Day Low
6.55
52W High
8
52W Low
4.33
Volume
137,110
Avg. Volume
-
Mkt Cap
2.45B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 10
$1.00
Oct 10
$0.10
Jul 10
$0.10
Apr 10
$0.09
Jan 10
$0.09
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.58
0.81
1.05
1.28
Expected EPS
1.2766569744
Actual EPS
N/A

Financials

-188.09%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
44.55MRevenue
-83.78MNet Income

Analyst Ratings

9.00Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BHC. It's not an investment recommendation.
Amazon
29
AMZN
Microsoft
27
MSFT
NVIDIA
27
NVDA
Apple
25
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceuticals sector, directly competing with Bausch Health's range of medical products.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a major player in the pharmaceuticals industry, offering products that compete across several of Bausch Health's key markets.
Novartis
NVS
Mkt Cap292.35B
Novartis AG competes in the pharmaceuticals and eye care sectors, overlapping with Bausch Health's product lines.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the pharmaceuticals industry, particularly in areas like dermatology and eye health, which are key for Bausch Health.
Merck
MRK
Mkt Cap366B
Merck & Co. is a competitor in the pharmaceuticals sector, with a broad product portfolio that competes with Bausch Health's offerings.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global competitor in generic and specialty medicines, competing with Bausch Health's diversified portfolio.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes in pharmaceuticals and consumer healthcare, directly competing with Bausch Health in several key areas.
Rogers
ROG
Mkt Cap2.24B
Roche Holding AG competes in pharmaceuticals and diagnostics, areas where Bausch Health is actively expanding its presence.

About

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Show more...
CEO
Thomas J. Appio
Employees
20300
Country
United States
ISIN
CA0717341071
WKN
000A2JQ1X

Listings

MX
MX
BHCN.MX
STU
DE
BVF.STU
TO
CA
BHC.TO
MU
DE
BVF.MU

0 Comments

Share your thoughts

FAQ

What is Bausch Health Companies stock price today?▼
The current price of BHC is $6.56 USD — it has decreased by -2.96% in the past 24 hours. Watch Bausch Health Companies stock price performance more closely on the chart.
What is Bausch Health Companies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bausch Health Companies stocks are traded under the ticker BHC.
Is Bausch Health Companies stock price growing?▼
BHC stock has risen by +3.8% compared to the previous week, the month change is a +4.29% rise, over the last year Bausch Health Companies has showed a -10.75% decrease.
What is Bausch Health Companies market cap?▼
Today Bausch Health Companies has the market capitalization of 2.45B
When is the next Bausch Health Companies earnings date?▼
Bausch Health Companies is going to release the next earnings report on October 29, 2026.
What were Bausch Health Companies earnings last quarter?▼
BHC earnings for the last quarter are 1.24 USD per share, whereas the estimation was 0.98 USD resulting in a +26.71% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bausch Health Companies revenue for the last year?▼
Bausch Health Companies revenue for the last year amounts to 44.55M USD.
What is Bausch Health Companies net income for the last year?▼
BHC net income for the last year is -83.78M USD.
Does Bausch Health Companies pay dividends?▼
Yes, BHC dividends are paid quarterly. The last dividend per share was 1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bausch Health Companies have?▼
As of September 05, 2026, the company has 20,300 employees.
In which sector is Bausch Health Companies located?▼
Bausch Health Companies operates in the Health & Wellness sector.
When did Bausch Health Companies complete a stock split?▼
Bausch Health Companies has not had any recent stock splits.
Where is Bausch Health Companies headquartered?▼
Bausch Health Companies is headquartered in QUEBEC, United States.